Skip to Content

Opulis

Active Substance: desloratadine
Common Name: desloratadine
ATC Code: R06AX27
Marketing Authorisation Holder: Schering-Plough Europe
Active Substance: desloratadine
Status: Withdrawn
Authorisation Date: 2001-01-15
Therapeutic Area: Urticaria Rhinitis, Allergic, Seasonal Rhinitis, Allergic, Perennial
Pharmacotherapeutic Group: Antihistamines for systemic use

Therapeutic Indication

Opulis is indicated for the relief of symptoms associated with:
- allergic rhinitis (see section 5.1)
- urticaria (see section 5.1)

The marketing authorisation for Opulis has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide